We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
The acute intervention will consist of intravenous administration of the GLP-1 receptor agonist exenatide or placebo.
2
Our results indicate that inflammation and hypoxia in adipose tissue can be mitigated by GLP-1 receptor agonist potentially via improved angiogenesis and microcirculation in obesity.
3
The mechanisms underlying the weight-loss effect of GLP-1 receptor agonists need further elucidation.
4
GLP-1 receptor agonists, which mimic the effects of GLP-1, have been developed for the treatment of type 2 diabetes.
5
Here, we to determine whether sequence differences at the ligand C-termini of clinically approved GLP-1 receptor agonists exendin-4 and lixisenatide lead to similar phenomena.
Usage of incretin mimetics in English
1
The drugs are part of a class known as incretinmimetics designed to induce the same effects as a blood sugar-improving hormone called GLP-1.
2
Both drugs are part of a class known as incretinmimetics designed to induce the same effects as a blood sugar-improving hormone called GLP-1.
3
The diabetes medicines are part of a class known as incretinmimetics designed to induce the same effects as a blood sugar-improving hormone called GLP-1.